Glaxo/IGI Nova Skin marketing deal moves Glaxo into non-Rx skin care market.
This article was originally published in The Rose Sheet
Executive Summary
GLAXO WELLCOME MOVING INTO NONPRESCRIPTION SKIN CARE WITH NOVA SKIN, an ethically marketed skin care line manufactured by IGI's Nova Skin Care division. Glaxo and IGI signed a distribution agreement Jan. 8, under which Glaxo will assume exclusive sales and marketing responsibilities for the skin care line. Glaxo Dermatology, which markets Glaxo's prescription dermatological products, will use its 90-person derm sales force to continue to distribute the line solely through dermatologists.